Ειδήσεις: UTICA | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

25/03 13:46 statnews.com

STAT+: Merck to buy Terns Pharmaceuticals in $6.7B deal

STAT+CANCER POLITICS PHARMACEUTICALS PHARMA DRUG DEVELOPMENT

25/03 13:42 yahoo.com

Cardinal Health (CAH) Emerged as a Key Contributor on Pharmaceutical Strength and Margin Expansion

Cardinal Health CAH pharmaceutical strength margin expansion key contributor industry growth

25/03 13:35 marketwatch.com

Merck makes a big move into new cancer treatments with a $6.7 billion buyout deal

Merck Terns Pharmaceuticals oncology leukemia acquisition $6.7B

25/03 12:51 investing.com

Merck to buy oncology firm Terns Pharmaceuticals in $6.7 billion deal

Merck Terns Pharmaceuticals oncology acquisition $6.7 billion targeted therapies

25/03 10:12 defenseworld.net

Insmed (NASDAQ:INSM) Price Target Raised to $213.00 at Bank of America

Insmed price target Bank of America Royal Bank of Canada Citigroup HC Wainwright

25/03 09:36 defenseworld.net

Leerink Partners Issues Positive Forecast for Insmed (NASDAQ:INSM) Stock Price

Insmed Leerink Partners price target outperform rating mixed analyst views biopharmaceutical

25/03 09:35 defenseworld.net

Amneal Pharmaceuticals, Inc. $AMRX Shares Purchased by Assenagon Asset Management S.A.

Amneal Pharmaceuticals Assenagon Asset Management Q4 holdings 13F filing hedge fund stock purchase

25/03 08:37 defenseworld.net

Head to Head Contrast: Eagle Pharmaceuticals (NASDAQ:EGRX) and Innovus Pharmaceuticals (OTCMKTS:INNVD)

Eagle Pharmaceuticals Innovus Pharmaceuticals valuation revenue earnings per share price‑to‑earnings ratio

25/03 07:26 defenseworld.net

Connect Biopharma (NASDAQ:CNTB) and BioMarin Pharmaceutical (NASDAQ:BMRN) Financial Comparison

Connect Biopharma BioMarin Pharmaceutical institutional ownership valuation insider holdings dividends

25/03 07:26 defenseworld.net

Connect Biopharma (NASDAQ:CNTB) and BioMarin Pharmaceutical (NASDAQ:BMRN) Financial Comparison

Connect Biopharma BioMarin Pharmaceutical institutional ownership valuation insider holdings dividends

Loading...